null0t? Q?#???null
0÷??F(?F?n)#]í
赖明亮,雷招宝(~ 8~ì g| ?Dy,~~ì331100)
T?eo: ? ü
(1967null),3,D V,???D =nullTe:l(0795)
6600036,Enullmai:lfcslzb@163.comnull
K1null"¥:了解药源性腮腺炎(腮腺肿胀)的有关知识,为临床安全用药提供参考bZE:检索国内三大数
据库(1979~2008年12月),下载有关文献进行归纳与分析b2T:致腮腺炎(腮腺肿胀)的药物种类繁多,
其中抗菌药物a肝病药物a减毒疫苗a抗胆碱药物等较为多见b2 ?:药源性腮腺炎(腮腺肿胀)的临床后果
并不严重,预后良好b
1oMnull药源性疾病;腮腺炎;腮腺肿胀;不良反应;预防;治疗
?ms ?|:R595.3nullnullnullóDS M ?:BnullnullnullócI|:1006-0111(2009)04-0311-03
nullnull?0t?¥?F?F?n?10÷??
F(drugnullinducedparotitis)0÷??F?n
(drugnullinducedswellingofparotidgland)b0÷??
F?F?n??? 38`,?|9nb''
óYVóD_ ì,ü?0÷??F?0÷??
F?n¥0ta "5?a "5VCa?h ?[#
?]Dí é?óD8 ?,1 "5D|?? ?¨
04? Ib
1null'' DZE
_ ìb?]Z?Sù ó ? o!a£Z
? D0?"d!???''??ó S/ù < ?
o!(1979~2008M12),[??F#a??F
?n#a??F?v#a?á#a??#a?? Q?#?
1_ ìMé?_ ì,1"×ˉ¥h èá?óD8
?,/'' ??¥h èáiu?,?aé?B
?ad9,i2?S?μ1óDé?sb
2null2T
2.1null文献分布情况null1"4é8 ??×ˉh è
á,¤μ1óD35é,s?25?D0?
,?0t? Q??!5é9 è,0t @?
hD?!4é5 è,?SDy0D?!2é5
è,D0?!2é7 è, e?ò1ésYá
1~13 è??b
2.2null致药源性腮腺炎的药品目录(nV1)
2.3null年龄与性别分布null?128 è'' 1???¥h
è9 ?,??M -S?19~78 ?,ü (M -1(35.
8?23.1) ?;3?83 è,o?45 è,3o1 è11.84null
1,3? üA?o?b
V1nullá0÷??F0?" c
0?s ?0??
F )0t?t , V ? í,h1:@,v?ì?,
Q g?J,+1Mo,h1??(5? ? í
%),ì í
ü"d0t ; ?r`, od`,y.í,d`,sd`, obo, o?ü,w ü? ü,J?
?ó50tb&1ü,D 51ü,sd / F í,t?, V á?,?YJ,G? ?
h?"d0t-??,?E\a,!??t, ;? ?a,,9à, ?D9à,? Z''?
??4? ???,?p,?/?44
3£?eh0t ü ?,? ü ?
?J0#£ù¨0 ? ,(ritodrine), o?[
f ì?Fhyf ì,?Fnull ?? ó?f ì
e0t?? ínullnull,? ê??? ?,J?,:,=
?d?, ?ì [,|óa?a,μ
j0?y
2.4null药源性腮腺炎的临床表现null0÷??F
?F?n(v) "5 ¥VC??áh¥0t?
]7μ ?μY,μ HμY??vb l"?¥h è
'' ,0÷??F?F?n(v)¥Kn¥ "
5?μ:?§ ?§?F?v,v ??n?v
)μ(eae,v ?μ g?,?F?5 gí£?
#s ?t,íe^#?£?b?s0tá?FQ
?YV? k(Q¨0)7¤?£ Lb
l?s0tμ+ y "5VC,? ü ???
ü ? V P?s??C?£a jt′a ???
?a0?a ? ¥?e,μ¥?? &????a
??a2aé?va?£?; Fú h0tá?
F?v¥] HCa% 6úa? &?êm?a? &
????;?tVC ??0t¥ e? Q?(
3110D Ll?null2009M?27 ?4ù
i??),?? ??0÷??F "5?- b
F?H2null s8Eì4 Vá?Fs ?tM??F5
E?; F?a0t?-??a?E\a?]?F8s
?/? g?¥] H?^? 3??,Qˉ¨0 VáQ
ˉ??F?v,μ¥?Fu?ea?5 g^ óa
£?aμs ?tna?£?b?0t¥M ?Q
? ?á? Vμ?£?b
3null) ?
3.1null药源性腮腺炎的临床诊断nullyp0÷??F
¥ "5? V? I[/+H:& P¨0tD?F
? 3μ ü?¥yT1";? ?§?§?F?v;
(μ^(eae; .íae?(e;)? k
(Q¨0) V P?F?F?n(v)? 3
¥.?ù üA ê, "5VC÷?×;? F )0t?
Fhy0tí ír(f ì??"?);+S=?
óDμ1??0??F?F?n(v)¥
áb??&~)H V[T \?¥0÷??F¥
"5?,?+ H VT1? Ib
3.2null药源性腮腺炎的致病机制
3.2.1null]??Fs ?[3,7]null F?a0tá?F
?F?n(v)¥T¨?ü ^YV?a A?a
T¨,EìM s8DY??a¥2?,V7 P?F
s ?h as ?tMa????,- ^v4
H P g8 ó £?,?F gMlbv ? Fú
h0t9μ F?aT¨,y79 V?0÷??
F?F?n(v)bF?H2null s8Eì45 ^Y
VEH2 s87E??F5¥s ?, P?Fs ?
tMbμ j0?y ?á¥?F?F?n
(v) V? ^=÷¥V?? P¨ -??? F?
a0t?b
3.2.2nullV ùQ?[4~6,8~11]null F )0t??t a
h1:@)a V ? í?? ;? ?aa?e?!??
ta?#?4a=?d?aJ?,:a|óa?
aa o?[?á?F?F?n(v)ü V?μV
ùQ???Db
3.2.3nullhyf ì'' &¥eyS=?óD
?[12]¤? ???Fhyf ì V? 3?F?
F?n(v),? 3 q11/10000~1/50000,à? ^
?Fhyf ì?? ^hyf ì(?ei%hˉ
μ?éB?ù?b
3.2.4null eeynullμt0tá?F?F?
n(v)¥ey? ü,μ?éB?ù?,1? ?ì
[?b
3.3null药源性腮腺炎的预防null??0÷??F
?F?n(v)¥2]??v,????¥ 3
/?ˉ},yN?]n @ V?i àμ¤?D
|????¥× jb ?Oi?? \? P¨?0
tt??üB???á?F?F?n
(v)bμ H??í ?]%h¥31, ?v
?@¥f ?/?¤- {0t¥á?F?T¨b
D5?N,μ Vê4¥0tf ?/,?^?
|?yp? P¨ Vá?F0tí ?];?
?B? P¨?0t? 3V?F?F?n
(v),?a?E ? P¨]"¥0tí b
3.4null药源性腮腺炎的治疗null?v ?0t ?
?,B?¨0V??? 30÷??Fo1T
0 ?l H ?°,?F?nü??vh|,í3é
?+ y¥í ,?áh0t8=h"a1??ˉ
?èb"- ?n?í 0tb?μi?? H
+Y ^?×¥i?? Hü??é??í b
μV ùQ???D¥0÷??F V P¨
FV ù0té??í , è?!??t ?á¥
?F? 1? ü ? V P ?l H3h=h >,? P
¨1? ü ???33d? P?F?nh >[10,11],
g? o& ù P?Fh >9 ¤b
4null2?
9-, V[á0÷??F?F?n(v)
¥0t? ,?0÷??F¥ "5?i??
×,2]??v,T0a1?h >,íaL?bμ
i?? H??1é?í b
? IóD:
[1]null±e ?,~Y.B? L¨8 SD[M].?:| ?? 3
? ,?7?,2005:757~758null
[2]nullY= ?,Kr,?3′,nr.+1Moá?F?v[J].0t
@?hD?,1999,8(4):252.
[3]null¢è.0t?¥?F[J].0t @?hD?,1996,5
(2):92null
[4]null?null,|null ?,ê?).h1:@)á?F?v8 èá
[J].?S uD =,2003,19(6):46.
[5]nullRí?,RyZ,Rya.0÷??F?v13 è[J].?SD
=?,2004,(9 <):93.
[6]null ù??, ??.÷ ? V ? íá?F?v6 è[J].| ? +
D,2004,47(9):558.
[7]null? ù, ?£i.?654null2#??AF?v[J].μ2DD,
1986,3(3):164null
[8]null|S?, ùnullá.áˉ ;? ?aá?F?v1 è[J].0t @
?hD?,2005,14(3):153.
[9]null$y?,?IP. ;? ?aá?F?v[J].0t? Q?
?,2007,9(5):378.
[10]null ùò?,?lü,?¥ ;,?.?e?!??tá?F?v?
èá[J]. "5?í,2008,21(2):77null
[11]nullb ??,?y?,|? á.!??tá?F4 è[J].D0?
312JoumalofPharmaceuticalPracticeVo.l272009No.4
,2005,24(4):298.
[12]null >nullü.¤? ??= óf ì??F?v12 èá[J].Z
+DD?,2006,27(4):310.
[13]nullThompsonDF.Drugnullinducedparotitis[J].JClinPharmTher.
1993,18(4):255null
[14]nullChauhanV,NegiRC,SharmaA,etal.Enalaprilatinducedacute
parotitis[J].JAssocPhysiciansIndia,2008,56(2):128null
là°ù:2008null12null15
57 èó ?Y? A ?á? Q?s
王陈翔,周子晔,叶其蓁(?üDDy? ??BDy,?~?ü325000)
T?eo:|?U(1982null),o,D V.Te:l(0577)88069550,
13587613784,Enullmai:lqiuqiuwcx@sohu.com.
K1null"¥:分析血栓通注射液的不良反应发生的特点,促进临床安全用药bZE:收集国内文献报道的57
例血栓通注射液引起的不良反应病例,并进行统计分析b2T:血栓通注射液的不良反应以过敏反应最为常
见,过敏性休克最严重b2 ?:临床医师应重视对血栓通注射液不良反应的监测,确保用药安全b
1oMnull血栓通注射液;不良反应;文献分析
?ms ?|:R969.3nullnullnullóDS M ?:BnullnullnullócI|:1006-0111(2009)04-0313-02
nullnulló ?Y ^?0?t¥4|t,?c?t90,
?1?s1|?0Rg1?Rb1bó ?Y? A
μ??7óa9F79?ah^?ó ?áh ? ?
],???%?,]?óle ",??ó?
?T¨[1], "5 ?1¨?í ò??ó?%h,
? j??á ?E?a7ó5haL?a=ha
-\óa ? ????e?b "5?¨V??
g Vn0t? Q?(ADR)b3?S=íM ?
1?ó ?Y? A ?áADR¥?é?? ??s
,1 "5¨04? Ib
1null'' ?÷DZE
_ ì?Sù ó ? o9 o(CNKI? ?
?)!D???S S/ù ó ? o!1998~
2008M¥'' , l"?ó ?Y? A¥ADR''
41é, #D0ù <21?,957 èb ?_ ì
¥ó ?Y? A? Q?é?s ?aB,a92b
2null2T
2.1null原发病和年龄分布null57 èADRsY? 3?
7ü?a7ü?aL?a7? ?ó?@a3?ha
=óa j?hM?¥í V??,?[7ü?
1n,927 è,]ADR9 ?¥47.36%,7 oM
| ^?t%h¥ú?|?,Q ^=ó13 è,
]9 ?¥22.81%b??Có ?Y? A P¨? a
ü ?[?¥?íh?b
57 èADRh è?,3?31 è,o?26 è;M
-Kv181 ?,Kl117 ?,??[60 ?[ ¥
oM|(25 è) ,]9 ?¥43.86%bM -s?W
nV1b
V1nulló ?Y? Aá? Q?
??¥M -s?(n=57)
FY( ?)3o
<2010
20~2911
30~3964
40~4954
50~5973
60~69510
,7064
2.2null发生时间null57 èADR?,?2 èADR
C HW???,?55 èC? Q?¥ HW,
K y¥1¨0a1min[2],K ¤¥1 ??¨012d
a[3];¨01~7d=CADR?K,]9 ?¥
42.10%,nV2b
V2nulló ?Y? Aá? Q?? 3 HWs?(n=57)
HW è ?(n)?s1(%)
3Synmin23.51
~30min915.79
~1d1526.32
~7d2442.10
~12d58.77
?W23.51
?957100
2.3nullADR类型及临床表现nulló ?Y? A¥ADR
???,?1 ^V ùQ?,Q ^0?a|sah
3130D Ll?null2009M?27 ?4ù
|
|